The PrP C is expressed in many types of immune cells including monocytes and macrophages, however, its function in immune regulation remains to be elucidated. In the present study, we examined a role for PrP 
INTRODUCTION
The cellular prion protein (PrP C ) is a 32 kDa glycosylphosphatidylinositol (GPI)-anchored glycoprotein found in specific structures of the cell membrane called lipid rafts (1) . The N-terminal half of PrP C is largely unstructured and is composed of a signal peptide and five octapeptide-repeat regions known to be binding sites for Cu 2＋ (2) . The C-terminal half of PrP C is folded into three alpha helices and two short beta-strands containing two oligosaccharide chains and a GPI-anchor at the end (3, 4) . Conformational conversion of PrP C to a misfolded protein termed scrapie prion protein (PrP   Sc   ) is a major pathogenesis of transmissible spongiform encephalopathies (TSE), or the prion diseases, in animals and humans (5, 6) . PrP C is highly expressed in the central nervous system (CNS) and this is the major site of prion pathology (7). PrP C is also expressed in many types of immune cells including lymphocytes, natural killer (NK) cells, monocytes, dendritic cells (DCs), macrophages, and follicular dendritic cells (8) (9) (10) (11) (12) . In addition, PrP C is known to be proteolytically shed by metalloproteinase (13, 14) , and a substantial amount of soluble PrP C is found in the culture medium of splenocytes and in human serum (15) . However, the function of membranebound PrP C or soluble PrP C in regulation of immune cells remains to be elucidated. Physiological roles for PrP C in monocytes and macrophages have been reported in several studies (16, 17) . Originally, PrP C was proposed to be a negative regulator of phagocytosis as macrophages from PrP C -deficient mice showed greater phagocytic activity than macrophages from wild-type mice (18) ; however, recent studies with another line of PrP C -deficient mice demonstrated that PrP C enhanced phagocytic activity of macrophages (19, 20) . In addition, pseudopodium extension arrest and cell detachment were observed in macrophages from PrP C -deficient mice (19) . The effects of soluble PrP C protein has also been studied (21) . In this regard, it was found that soluble PrP C protein activated several signaling proteins in mouse monocyte/macrophage cells, including ERK-1/2 and Akt kinase which are known to regulate phagocytosis, migration, and cytokine production by monocytes (21) .
In the present study, we further investigated a role for PrP 
MATERIALS AND METHODS
Reagents LPS was purchased from Invivogen (San Diego, CA). PMA was purchased from Sigma-Aldrich (St. Louis, MO). PD98059, SN50, and SB203580 were purchased from Calbiochem-Behring (La Jolla, CA). FITC-conjugated Abs against CD1a and CD11b, and control IgG were purchased from BD Biosciences (San Jose, CA). Abs against ERK-1/2, IKK, Iκ B, and the phosphorylated form of each protein were purchased from Cell Signaling Technology (Beverly, MA).
Cells and cell culture
Human monocytic leukemia THP-1 cells were obtained from American Type Culture Collection (Manassas, VA). Human primary monocytes were obtained from PBMCs of normal donors. Primary monocytes were isolated from PBMCs with CD14 magnetic beads (Miltenyi Biotec, Auburn, CA). The purity of the isolated monocytes was verified with anti-CD14-FITC Ab (BD Biosciences) staining and flow cytometric analysis. The purity of isolated human monocytes was typically 90 ∼94%. THP-1 Blue TM cells, which are THP-1 cells with an NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter, were purchased from Invivogen. Cell culture was maintained in RPMI-1640 medium supplemented with 10% heat-inactivated FBS, penicillin G (100 IU/ml), streptomycin (100μg/ml), L-glutamine (2 mM), HEPES (10 mM), and sodium pyruvate (1.0 mM). Soluble PrP C binding assays to monocytes Human primary monocytes were fixed with 4% paraformaldehyde for 10 min and blocked with 5% normal goat serum for 30 min. They were then incubated with control Fc or with soluble PrP C -Fc at various concentrations, followed by labeling with FITC-conjugated anti-human IgG. Flow cytometry was performed using LSRII (BD Biosciences), and the data were analyzed using FlowJo software (Treestar, San Carlos, CA).
Cell adherence assay and phagocytosis assay Cell adhesion assay was performed as described previously (22) . Briefly, ten thousand THP-1 cells were plated in each well of a 96-well culture plate and treated with soluble 
Western blot
To analyze levels of ERK-1/2, IKK, Iκ B, and the phosphorylated form of each protein, cells were lysed in ice-cold lysis buffer (50 mM Tris−HCl, pH 7.4, containing 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 0.1% deoxycholate, 5 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM 4-nitrophenyl phosphate, 10μg/ml of leupeptin, 10μg/ml of pepstatin A, and 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride). Cell lysates were centrifuged at 15,000 g for 5 min at 4 o C. The supernatant was mixed with SDS sample buffer, boiled for 5 min, and then separated by 12% SDS−PAGE. The protein was transferred to nylon membranes by electrophoretic transfer. The membrane was blocked in 5% skim milk, rinsed, and incubated with a specific Ab in PBST overnight at 4 o C. The membrane was rinsed four times in PBST, and incubated with 0.1μg/ml peroxidase-labeled secondary Ab for 1 h. After rinsing three times in PBST, specific bands were visualized by enhanced chemiluminescence. (Fig. 1A) . First, we evaluated whether soluble PrP (Fig.  2A) . Moreover, after two days of culture with soluble PrP C -Fc, THP-1 cells became flattened and exhibited a macrophagelike morphology, similar to that seen with PMA treatment (Fig. 2B) . The expression of CD1a and CD11b on the cell surface of human monocytes was also significantly increased in response to soluble PrP C -Fc (Fig. 2C) . Next, we studied phagocytic activity by co-culturing human monocytes with mRFP-expressing E. coli. As measured by flow cytometry, we found that after 48 hours of culture with soluble PrP C -Fc, phagocytic activity of human monocytes was significantly enhanced in a dose-dependent manner (Fig. 2D) . Taken together, soluble PrP (Fig. 3) .
Soluble PrP
C -Fc activates signaling pathways for ERK and NF-κB Next, we studied whether soluble PrP C -Fc activates intracellular signaling pathways in THP-1 cells. In particular, we investigated activation of ERK and NF-κB, which are known to regulate differentiation of monocytes and production of pro-inflammatory cytokines (23) . Following soluble PrP C -Fc treatment, phosphorylation of ERK-1/2 was increased while the total amount of ERK-1/2 remained unchanged (Fig. 4A) . A MEK-specific inhibitor, PD98059, abrogated ERK-1/2 phosphorylation induced by soluble PrP C -Fc (Fig. 4A) . In addition, soluble PrP C -Fc increased phosphorylation of IKK and IκBα in monocytes (Fig. 4B) , suggesting that the NF-κB pathway is also activated in response to PrP C -Fc treatment. We further evaluated NF-κB activity using a SEAP reporter assay in which THP-1 Blue TM cells secrete SEAP into the culture supernatant upon NF-κB activation. We found that NF-κB activity was increased in response to soluble PrP C -Fc in a dose-dependent manner, but not by heat-denatured PrP C -Fc (Fig. 4C) .
Monocyte adherence and cytokine production by soluble PrP C -Fc depend on ERK and NF-κB signaling As soluble PrP C -Fc activates ERK and NF-κB in monocytes, we studied whether ERK or NF-κB signaling is responsible for the downstream effects stimulated by this protein. To elucidate the role of each signaling pathway, we treated cells with specific signaling inhibitors including PD98059 to inhibit the ERK pathway and SN50 to inhibit the NF-κB pathway, one hour before soluble PrP C -Fc treatment. SB203580 was also used to inhibit the p38 signaling pathway. First, we found that THP-1 cell adherence induced by soluble PrP significantly inhibited by PD98059 and by SN50, but not by SB203580 (Fig. 5A) . Pro-inflammatory cytokine production by monocytes was also studied. Similar to cell adherence, soluble PrP C -Fc-induced production of TNF-α and IL-1β was significantly inhibited by PD98059 and by SN50, but not by SB203580 treatment (Fig. 5B) . Taken together, soluble PrP C -Fc induces adherence and cytokine production of monocytes via activation of ERK and NF-κ B.
DISCUSSION

PrP
C is a GPI-anchored protein found in lipid rafts of the cell membrane and expressed in immune cells as well as cells of the central nervous system. While PrP C is known to be proteolytically shed by metalloproteinase (13, 14) , and a substantial amount of soluble PrP C is found in the culture medium of splenocytes and in human serum (15) , the precise function of soluble PrP C in immune regulation is unknown.
In the present study, we investigated the roles for the soluble form of PrP C in the regulation of monocytes and found that this molecule enhanced the adherence and phagocytic activity of these cells. Furthermore, soluble PrP C stimulated monocytes to produce pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6. The effect of soluble murine PrP C protein on monocytes was previously examined. In this study, a recombinant murine PrP C -Fc fusion protein was generated in a manner similar to the one we used to generate recombinant human PrP (Fig. 1B) and in a previous study (21), we did not identify a binding partner for soluble PrP C on the surface of monocytes. PrP C is known to bind to the neural cell adhesion molecule (N-CAM) (24) , and to the laminin receptor and laminin receptor precursor protein (25) (26) (27) . A putative role for a homotypic interaction between soluble PrP C and membrane PrP C also needs to be investigated. All these possibilities need to be investigated in future studies. Physiological roles of PrP C in monocytes and macrophages have been studied in PrP C knockout mice. Originally, PrP C was proposed to act as a negative regulator of phagocytosis because macrophages from PrP C -deficient mice showed higher phagocytic activity than those from wild-type mice (18) . In contrast, recent studies with another line of PrP C -deficient mice demonstrated that PrP C enhanced phagocytic activity of macrophages (19, 20) . In addition, pseudopodium extension arrest and cell detachment were observed in macrophages from PrP C -deficient mice (19) . In the present study, we focused on the effects of the soluble form of PrP C on monocytes and showed that soluble PrP C protein enhanced cell adherence and phagocytic activity of monocytes. Our results are consistent with the more recent studies with PrP C knockout mice (19, 20) , however, membrane-bound PrP C and soluble PrP C need to be considered separately when data from PrP C knockout mice are interpreted.
In conclusion, we studied the function of soluble PrP C protein in regulation of monocyte function using a recombinant form of soluble human PrP C fused with the Fc portion of IgG1. We found that soluble PrP C -Fc enhanced adherence, phagocytosis, and cytokine production by monocytes via activation of the ERK and NF-κB signaling pathways. Detailed mechanisms for the action of soluble PrP C on monocytes will be further investigated in subsequent studies.
